Treatment usually begins with a 0.25 mg weekly dose for 4 weeks (for tolerability), then increases to 0.5 mg weekly, with a maintenance dose of 0.5-1 mg weekly as determined by your healthcare professional
Park J, Jung H, Jang B, Song H-K, Han I-O, Oh E-S
(2017) which provided a mean age of 60.9 years for participants (Table 2)
FeliceMDRenardJHudsonRSzkudlarekHJPereiraBJSchmidSet alL-theanine prevents long-term affective and cognitive side effects of adolescent Delta-9-Tetrahydrocannabinol exposure and blocks associated molecular and neuronal abnormalities in the mesocorticolimbic circuitry
The experimental model implies that the erectile deficit secondary to La Peyronie's disease is due to an arterial deficiency
We hear this all the time